The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP
Abstract
Long non-coding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) has been reported to be involved in the development and progression of many types of tumors including breast cancer, gastric cancer, and bladder cancer. However, the exact effects and molecular mechanisms of UCA1 in glioma progression remain unclear up to now. In this study, we firstly found that UCA1 was upregulated in glioma tumor samples and negatively correlated with survival time. Then, we investigated the role of UCA1 in human glioma cell lines. Our results showed that upregulation of lncRNA-UCA1 in glioma tissues and cell lines could promote glioma cell proliferation and migration through interaction with miR-182, and knockdown of UCA1 inhibited the proliferation and migration of human glioma cell. In addition, miR-182 dependent inhibitor of apoptosis-stimulating protein of p53 (iASPP) was required in the regulation of UCA1 induced glioma cell proliferation. Taken together, UCA1 might promote proliferation and migration of glioma, to regulate the tumor growth and metastasis via miR-182 dependent iASPP regulation. Therefore, lncRNA-UCA1 could be regarded as a therapeutic target in human glioma.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Two lncRNAs, H19 and UCA1, regulate glioblastoma progression by interacting with mir-140 and mir-182, respectively.
“Two lncRNAs, H19 and UCA1, regulate GBM progression by interacting with mir-140 and mir-182, respectively.”
From The p53 Pathway in Glioblastoma (2018) · cites this paper as [57]
H19 and UCA1 reduce the expression and activity of mir-140 and mir-182, and therefore possess p53-dependent oncogenic activity in glioblastoma.
“H19 and UCA1 reduce the expression and activity of these miRNAs, and therefore possess p53-dependent oncogenic activity in GBM [57,58].”
From The p53 Pathway in Glioblastoma (2018) · cites this paper as [57]
Cites
1 retracted
MicroRNA-124 Regulates the Proliferation of Colorectal Cancer Cells by TargetingiASPP
Liu, K., Zhao, H., Yao, H., Lei, S., Lei, Z., Li, T., & Qi, H. (2013) · BioMed Research International · doi:10.1155/2013/867537 · Cited by 56 · see citing works
RetractedLandscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187 · see citing works
Evolution and Functions of Long Noncoding RNAs
Ponting, C. P., Oliver, P. L., & Reik, W. (2009) · Cell · doi:10.1016/j.cell.2009.02.006 · Cited by 4,917 · see citing works
Analyzing MiRNA–LncRNA Interactions
Paraskevopoulou, M. D., & Hatzigeorgiou, A. G. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3378-5_21 · Cited by 895 · see citing works
Standards of care for treatment of recurrent glioblastoma—are we there yet?
Weller, M., Cloughesy, T. F., Perry, J., & Wick, W. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos273 · Cited by 766 · see citing works
Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
Martens‐Uzunova, E. S., Böttcher, R., Croce, C. M., Jenster, G. W., Visakorpi, T., & Călin, G. A. (2013) · European Urology · doi:10.1016/j.eururo.2013.12.003 · Cited by 656 · see citing works
LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p
Nie, W., Ge, H., Yang, X., Sun, X., Huang, H., Tao, X., Chen, W., & Li, B. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.024 · Cited by 354 · see citing works
Yl, T., Xm, L., & Luo, J. (2015) · PubMed · Cited by 286 · see citing works
Han, Y., Yang, Y., Yuan, H.-H., Zhang, T., Sui, H., Wei, X.-L., Liu, L., Huang, P., Zhang, W., & Bai, Y. (2014) · Pathology · doi:10.1097/pat.0000000000000125 · Cited by 241 · see citing works
Regulation of lncRNA expression
Wu, Z., Liu, X., Liu, L., Deng, H., Zhang, J., Xu, Q., Cen, B., & Ji, A. (2014) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-014-0212-6 · Cited by 233 · see citing works
Frosch, M. P., Anthony, D. C., & Girolami, U. D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0792-2.50033-x · Cited by 228 · see citing works
Pan, J., Li, X., Wu, W., Xue, M., Hou, H., Zhai, W., & Chen, W. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.015 · Cited by 217 · see citing works
Vigneswaran, K., Neill, S. G., & Hadjipanayis, C. G. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.57 · Cited by 157 · see citing works
Wang, L., Shi, Z., Jiang, C., Liu, X., Chen, Q.-D., Qian, X., Li, D., Ge, X. Q., Wang, X.-F., Liu, L.-Z., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2116 · Cited by 143 · see citing works
Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer
Li, H.-J., Li, X., Pang, H., Pan, J., Xie, X., & Chen, W. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv132 · Cited by 137 · see citing works
Xiao, C., Ch, W., & Hz, H. (2016) · PubMed · Cited by 136 · see citing works
Shang, C., Guo, Y., Zhang, J., & Huang, B. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3029-3 · Cited by 116 · see citing works
Analysis of the mi RNA – mRNA –lnc RNA networks in ER + and ER − breast cancer cell lines
Wu, Q., Guo, L., Jiang, F., Li, L., Zhong, L., & Chen, F. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12681 · Cited by 106 · see citing works
An emerging understanding of long noncoding RNAs in kidney cancer
Zhou, S., Wang, J., & Zhang, Z. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1699-y · Cited by 105 · see citing works
Wei, Y., Sun, Q., Zhao, L., Wu, J., Chen, X., Wang, Y., Zang, W., & Zhao, G. (2016) · Medical Oncology · doi:10.1007/s12032-016-0804-2 · Cited by 97 · see citing works
Self-citationThe lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP
Zhao, H., Peng, R., Liu, Q., Liu, D., Du, P., Yuan, J., Peng, G., & Liao, Y. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.09.014 · Cited by 86 · see citing works
Li, A., Lin, X., Tan, X., Yin, B., Han, W., Zhao, J., Yuan, J., Qiang, B., & Peng, X. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.06.018 · Cited by 85 · see citing works
Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness
Emdad, L., Janjic, A., Alzubi, M. A., Hu, B., Santhekadur, P. K., Menezes, M. E., Shen, X., Das, S. K., Sarkar, D., & Fisher, P. B. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou220 · Cited by 83 · see citing works
Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation
Tao, T., Cheng, C., Ji, Y., Xu, G., Zhang, J., Zhang, L., & Shen, A. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-09-0805 · Cited by 75 · see citing works
Yang, M., Yu, J., Jiang, D., Li, W., Wang, S., & Ding, Y. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-109 · Cited by 71 · see citing works
Yu, Y., Huang, J., Zhang, X., & Shen, L. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2382-6 · Cited by 68 · see citing works
microRNA-214-mediated UBC9 expression in glioma
Zhao, Z., Tan, X., Zhao, A.-N., Zhu, L., Yin, B., Yuan, J., Qiang, B., & Peng, X. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.11.097 · Cited by 50 · see citing works
miR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a.
Sun, J., Ji, J., Huo, G., Song, Q., & Zhang, X. (2015) · PubMed Central · Cited by 50 · see citing works
Tumorigenic Potential of miR-18A* in Glioma Initiating Cells Requires NOTCH-1 Signaling
Turchi, L., Debruyne, D. N., Almairac, F., Virolle, V., Fareh, M., Neirijnck, Y., Burel‐Vandenbos, F., Paquis, P., Junier, M., Obberghen‐Schilling, E. V., et al. (2013) · Stem Cells · doi:10.1002/stem.1373 · Cited by 50 · see citing works
Adamson, D. C., Rasheed, B. A., McLendon, R. E., & Bigner, D. D. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0177 · Cited by 45 · see citing works
Long non-coding RNA UCA1 is a predictive biomarker of cancer
Hong, H., Hou, L., Pan, X., Wu, C., Huang, H., Li, B., & Nie, W. (2016) · Oncotarget · doi:10.18632/oncotarget.10142 · Cited by 44 · see citing works
脳内出血で発症した転移性extraskeletal myxoid chondrosarcomaの1例
晏, 小., 寺川雄三, 徹, 山., & 中西, 愛. (2008) · Neuro-Oncology · doi:10.11452/neurooncology2005.17.1_1 · Cited by 34 · see citing works
iASPP Inhibition: Increased Options in Targeting the p53 Family for Cancer Therapy
Bell, H. S., & Ryan, K. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0182 · Cited by 33 · see citing works
Yi, H., Huang, Y., Yang, F., Liu, W., He, S., & Hu, X. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.05.002 · Cited by 32 · see citing works
Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell
Lü, L., Shen, Y., Tseng, K., Liu, W., Duan, H., & Meng, W. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160628 · Cited by 32 · see citing works
MicroRNA124 regulate cell growth of prostate cancer cells by targeting iASPP.
Chen, J., Xiao, H., Huang, Z., Hu, Z., Qi, T., Zhang, B., Tao, X., & Liu, S. (2014) · PubMed Central · Cited by 20 · see citing works
Yan, Y., McArthur, G. A., Hamid, O., Puzanov, I. J., Gonzalez, R. C., Gajewski, T. F., Wang, Y., Wongchenko, M. J., Choong, N. W., & Ribas, A. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-s1-o12 · Cited by 18 · see citing works
Self-citationLiu, X., Kang, J. P., Liu, F., Wen, S., Zeng, X., Liu, K., Luo, Y., Ji, X., & Zhao, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-4503-y · Cited by 15 · see citing works
Gene expression profiling of microRNAs associated with UCA1 in bladder cancer cells
Xie, X., Pan, J., Wei, L.-Q., Wu, S., Hou, H., Li, X., & Chen, W. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3357 · Cited by 13 · see citing works
Flagged first, then by citations
4 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The p53 Pathway in Glioblastoma
Zhang, Y., Dube, C., Gibert, M., Cruickshanks, N., Wang, B., Coughlan, M., Yang, Y., Setiady, I., Deveau, C., Saoud, K., et al. (2018) · Cancers · doi:10.3390/cancers10090297 · Cited by 440 · see citing works
Rynkeviciene, R., Simiene, J., Strainiene, E., Stankevicius, V., Usinskiene, J., Miseikyte Kaubriene, E., Meskinyte, I., Cicenas, J., & Suziedelis, K. (2018) · Cancers · doi:10.3390/cancers11010017 · Cited by 136 · see citing works
Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma
Voce, D. J., Bernal, G. M., Wu, L., Crawley, C. D., Zhang, W., Mansour, N. M., Cahill, K. E., Szymura, S. J., Uppal, A., Raleigh, D. R., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2170 · Cited by 92 · see citing works
Xu, F., & Zhang, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.103 · Cited by 89 · see citing works
The Role of lncRNAs in the Distant Metastasis of Breast Cancer
Wu, Y., Shao, A., Wang, L., Hu, K., Yu, C., Pan, C., & Zhang, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00407 · Cited by 89 · see citing works
Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity
Yu, L., Zhao, J. K., & Gao, L. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23350 · Cited by 87 · see citing works
Zheng, Z., Pang, C., Yang, Y., Duan, Q., Zhang, J., & Liu, W. (2017) · Journal of International Medical Research · doi:10.1177/0300060517726441 · Cited by 83 · see citing works
Lin, X., Spindler, T. J., Fonseca, M. A. D. S., Corona, R. I., Seo, J.-H., Dezem, F. S., Li, L., Lee, J. M., Long, H. W., Sellers, T. A., et al. (2019) · iScience · doi:10.1016/j.isci.2019.06.025 · Cited by 83 · see citing works
The prognostic value and mechanisms of lncRNA UCA1 in human cancer
Yao, F., Wang, Q., & Wu, Q. (2019) · Cancer Management and Research · doi:10.2147/cmar.s200436 · Cited by 82 · see citing works
Self-citationJahangiri, B., Khalaj‐Kondori, M., Asadollahi, E., & Sadeghizadeh, M. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0471-5 · Cited by 78 · see citing works
He, Z., You, C., & Zhao, D. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.091 · Cited by 77 · see citing works
Self-citationCrosstalk between long noncoding RNA and microRNA in Cancer
Bhattacharjee, R., Prabhakar, N., Kumar, L., Bhattacharjee, A., Kar, S., Malik, S., Kumar, D., Ruokolainen, J., Negi, A., Jha, N. K., et al. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00806-9 · Cited by 72 · see citing works
He, H., Wang, N., Yi, X., Tang, C., & Wang, D. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0193-z · Cited by 70 · see citing works
UCA1 long non-coding RNA: An update on its roles in malignant behavior of cancers
Ghafouri‐Fard, S., & Taheri, M. N. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109459 · Cited by 67 · see citing works
Survey of miRNA-miRNA cooperative regulation principles across cancer types
Shao, T., Wang, G., Chen, H., Xie, Y., Jin, X., Bai, J., Xu, J., Li, X., Huang, J. H., Jin, Y., et al. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby038 · Cited by 61 · see citing works
Sun, Y., Jin, J., Mi, W., Hao-Wu, Zhang, S., Meng, Q., & Zhang, S. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14934860122864 · Cited by 60 · see citing works
RetractedRen, S., & Xu, Y. (2019) · Cancer Science · doi:10.1111/cas.14002 · Cited by 59 · see citing works
Tune, B. X. J., Sim, M. S., Poh, C. L., Guad, R. M., Choy, K. W., Hazarika, I., Das, A., Gopinath, S. C. B., Rajan, M., Sekar, M., et al. (2022) · Journal of Oncology · doi:10.1155/2022/3249766 · Cited by 61 · see citing works
Non-coding RNAs and glioblastoma: Insight into their roles in metastasis
Mousavi, S. M., Derakhshan, M., Baharloii, F., Dashti, F., Mirazimi, S. M. A., Mahjoubin‐Tehran, M., Hosseindoost, S., Goleij, P., Rahimian, N., Hamblin, M. R., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.12.015 · Cited by 56 · see citing works
Momtazmanesh, S., & Rezaei, N. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.712786 · Cited by 55 · see citing works
LncRNA DGCR5 plays a tumor-suppressive role in glioma via the miR-21/Smad7 and miR-23a/PTEN axes
He, Z., Long, J., Yang, C., Gong, B., Cheng, M., Wang, Q., & Tang, J. X. (2020) · Aging · doi:10.18632/aging.103800 · Cited by 52 · see citing works
Self-citationEpigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer
Neve, B., Jonckheere, N., Vincent, A., & SEUNINGEN, I. V. (2018) · Cancers · doi:10.3390/cancers10110440 · Cited by 53 · see citing works
Li, Z., Liu, H., Zhong, Q., Wu, J., & Tang, Z. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12533 · Cited by 52 · see citing works
Liang, C., Yang, Y., Guan, J., Lv, T., Qu, S., Fu, Q., & Zhao, H. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.07.036 · Cited by 50 · see citing works
He, C., Lu, X., Yang, F., Qin, L., Guo, Z., Sun, Y., & Wu, J. (2019) · Bioscience Reports · doi:10.1042/bsr20181465 · Cited by 47 · see citing works
Xu, Y., Yao, Y., Leng, K., Li, Z., Qin, W., Zhong, X., Kang, P., Wan, M., Jiang, X., & Cui, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.21884 · Cited by 45 · see citing works
Crosstalk between the lnc RNA UCA 1 and micro RNA s in cancer
Wei, X., Yu, H., Zhang, X., & Song, D. (2019) · FEBS Letters · doi:10.1002/1873-3468.13470 · Cited by 43 · see citing works
Luo, Y., Ouyang, J., Zhou, D., Zhong, S., Wen, M., Ou, W., Yu, H., Jia, L., & Huang, Y. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-4915-9 · Cited by 42 · see citing works
Zhou, Q., Liu, J., Quan, J., Liu, W., Tan, H. Q., & Li, W. (2018) · Gene · doi:10.1016/j.gene.2018.05.054 · Cited by 37 · see citing works
CDK1 interacts with iASPP to regulate colorectal cancer cell proliferation through p53 pathway
Gan, W., Zhao, H., Li, T., Liu, K., & Huang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17794 · Cited by 36 · see citing works
Gao, L., Fu, S. K., Liu, F., Wu, H., & Li, W. (2021) · Pharmacology · doi:10.1159/000515901 · Cited by 35 · see citing works
Zhang, Y., Min, Z., Sun, Y., Li, W., Wang, Y., & Yu, W. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15199531937158 · Cited by 34 · see citing works
Self-citationBi, Y., Shen, G., Quan, Y., Jiang, W., & Xu, F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26813 · Cited by 34 · see citing works
Wang, X., Zhang, Y., Zheng, J., Yao, C., & Lu, X. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02753-y · Cited by 34 · see citing works
LncRNA UCA1 facilitated cell growth and invasion through the miR-206/CLOCK axis in glioma
Huang, Z., Zhao, X., Wu, X., Xiang, L., Yuan, Y., Zhou, S., & Yu, W. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1023-7 · Cited by 33 · see citing works
The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target
Sameti, P., Tohidast, M., Amini, M., Bahojb Mahdavi, S. Z., Najafi, S., & Mokhtarzadeh, A. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02972-0 · Cited by 32 · see citing works
The Functional Role of Long Non-coding RNA UCA1 in Human Multiple Cancers: a Review Study
Hosseini, N. F., Manoochehri, H., Khoei, S. G., & Sheykhhasan, M. (2020) · Current Molecular Medicine · doi:10.2174/1566524020666200619124543 · Cited by 32 · see citing works
Aberrant lncRNA Expression in Multiple Myeloma
Meng, H., Han, L., Hong, C., Ding, J., & Huang, Q. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x15123872205507 · Cited by 30 · see citing works
Construction of a ceRNA network reveals potential lncRNA biomarkers in rectal adenocarcinoma
Zhang, Z., Wang, S., Ji, D., Qian, W., Wang, Q., Li, J., Gu, J., Peng, W., Hu, T., Ji, B., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6296 · Cited by 29 · see citing works
Self-citationXin, H., Liu, N., Xu, X., Zhang, J., Yu, L., Ma, Y. C., Li, G., & Liang, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28777 · Cited by 27 · see citing works
RetractedRamaiah, M. J., Karthikeyan, D., Kumar, S. K., & Yamajala, R. B. R. D. (2019) · Gene · doi:10.1016/j.gene.2019.144126 · Cited by 27 · see citing works
Long non-coding RNAs in brain tumors
Katsushima, K., Jallo, G. I., Eberhart, C. G., & Perera, R. J. (2021) · NAR Cancer · doi:10.1093/narcan/zcaa041 · Cited by 24 · see citing works
Kciuk, M., Yahya, E. B., Mohamed, M. M. I., Abdulsamad, M. A., Allaq, A. A., Gielecińska, A., & Kontek, R. (2023) · Cancers · doi:10.3390/cancers15133298 · Cited by 28 · see citing works
Identification of transcription factor-miRNA-lncRNA feed-forward loops in breast cancer subtypes
Jiang, L., Yu, X., Ma, X., Liu, H., Zhou, S., Zhou, X., Meng, Q., Wang, L., & Jiang, W. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.11.008 · Cited by 25 · see citing works
Exploring Long Noncoding RNAs in Glioblastoma: Regulatory Mechanisms and Clinical Potentials
Zeng, T., Li, L., Zhou, Y., & Gao, L. (2018) · International Journal of Genomics · doi:10.1155/2018/2895958 · Cited by 24 · see citing works
Zhang, Y., Xiao, Y., Li, G., Gong, F., Zhang, X., & Hou, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.08.016 · Cited by 23 · see citing works
Metastasis associated long noncoding RNAs in glioblastoma: Biomarkers and therapeutic targets
Yadav, G., & Kulshreshtha, R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30577 · Cited by 22 · see citing works
Horita, K., Kurosaki, H., Nakatake, M., Ito, M., Kono, H., & Nakamura, T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.125 · Cited by 22 · see citing works
Cheng, M., Wang, Q., Chen, L., Zhao, D., Tang, J. X., Xu, J., & He, Z. (2022) · Human Pathology · doi:10.1016/j.humpath.2022.02.016 · Cited by 22 · see citing works
Self-citationRAD21 inhibited transcription of tumor suppressor MIR4697HG and led to glioma tumorigenesis
Mao, Y., Shen, G., Su, Z., Du, J., Xu, F., & Yu, Y. Q. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109759 · Cited by 21 · see citing works
Nasrollahzadeh-Khakiani, M., Emadi‐Baygi, M., & Nikpour, P. (2017) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.9448 · Cited by 20 · see citing works
Lei, B., Yu, L., Jung, T., Deng, Y., Xiang, W., Liu, Y., & Qi, S. (2018) · Journal of Neurological Surgery Part A Central European Neurosurgery · doi:10.1055/s-0038-1655549 · Cited by 20 · see citing works
Mukherjee, S., & Pillai, P. P. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.130065 · Cited by 18 · see citing works
Ge, B., & Li, G. (2020) · The Journal of Gene Medicine · doi:10.1002/jgm.3247 · Cited by 18 · see citing works
Qin, L., Jia, Z., Xie, D., & Liu, Z. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27344 · Cited by 17 · see citing works
RetractedLi, Z., Xiang, W., Shui, S., Han, X., Guo, D., & Lei, Y. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29467 · Cited by 16 · see citing works
LncRNA FAM181A-AS1 promotes gliomagenesis by sponging miR-129-5p and upregulating ZRANB2
Jiang, X., & Chen, D. (2020) · Aging · doi:10.18632/aging.103391 · Cited by 13 · see citing works
Ghaemi, S., Fekrirad, Z., Zamani, N., Rahmani, R., & Arefian, E. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2047191 · Cited by 13 · see citing works
Aria, H., Azizi, M., Nazem, S., Mansoori, B., Darbeheshti, F., Niazmand, A., Daraei, A., & Mansoori, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35208 · Cited by 12 · see citing works
Chang, L., Hu, Z., Zhou, Z., & Zhang, H. (2018) · RSC Advances · doi:10.1039/c8ra02090f · Cited by 11 · see citing works
RetractedLin, D., Li, W., Zhang, N., & Cai, M. M. (2022) · IET Systems Biology · doi:10.1049/syb2.12046 · Cited by 11 · see citing works
SNHG17 drives malignant behaviors in astrocytoma by targeting miR-876-5p/ERLIN2 axis
Du, F., & Hou, Q. (2020) · BMC Cancer · doi:10.1186/s12885-020-07280-8 · Cited by 11 · see citing works
Liu, C., Jin, J., Shi, J. F., Wang, L., Gao, Z., Guo, T., & He, Y. (2019) · Bioscience Reports · doi:10.1042/bsr20180995 · Cited by 10 · see citing works
Sun, Y., Shen, Y., & Li, X. (2021) · Bioengineered · doi:10.1080/21655979.2021.1995573 · Cited by 9 · see citing works
RetractedWang, J., Chen, X.-L., Han, Z., Wang, H., Wang, Z.-H., Li, N.-N., & Lin, Z. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146886 · Cited by 9 · see citing works
FAM87A as a Competing Endogenous RNA of miR-424-5p Suppresses Glioma Progression by Regulating PPM1H
Xu, H., Zhang, H., Tan, L., Yang, Y., Wang, H., Zhao, Q., & Lu, J. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/7952922 · Cited by 8 · see citing works
RetractedLiu, H., & Hu, K. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820962092 · Cited by 8 · see citing works
Lou, J., Wang, P., Chang, K., Wang, G., Geng, X., Wu, Y., Zhang, W., & Niu, G. (2021) · PubMed Central · Cited by 8 · see citing works
The miR-183/96/182 cluster is upregulated in glioblastoma carrying EGFR amplification
Schneider, B., William, D., Lamp, N., Zimpfer, A., Henker, C., Classen, C. F., & Erbersdobler, A. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04435-y · Cited by 8 · see citing works
Zou, H., Zou, R., Chen, K., Zhu, C., Tian, X., You, Y., & He, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27189 · Cited by 7 · see citing works
Molecular Pathological Markers Correlated With the Recurrence Patterns of Glioma
Ge, S., Shi, Y., Zhu, G., Li, S., Cai, Y., Ji, P., Liu, J., Guo, W., Gong, L., Lou, M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.565045 · Cited by 6 · see citing works
Self-citationRoles of long non-coding RNAs in the hallmarks of glioma.
Xue, B., Xiang, W., Zhang, Q., Wang, Y., Wang, H., Yi, D., Xiong, N., Jiang, X., Zhao, H., & Fu, P. (2020) · PubMed Central · doi:10.3892/ol.2020.11944 · Cited by 5 · see citing works
Self-citationMukherjee, S., Kundu, U., Desai, D., & Pillai, P. P. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02069-9 · Cited by 3 · see citing works
Cao, B., Luo, J., Xiao, S., & Zhou, X. (2022) · Biocell · doi:10.32604/biocell.2022.019613 · Cited by 3 · see citing works
Hooshmandi, S., Jangholi, E., Heidarian, A., Dehghani, M., Ghassemi, A., Heidary, A., Rezvanimehr, A., Sadeghi, E., Ghodsi, S. M., Hoseinian, M., et al. (2025) · Precision Medical Sciences · doi:10.1002/prm2.70003 · Cited by 1 · see citing works
LncRNA CAI2 Contributes to Poor Prognosis of Glioma through the PI3K-Akt Signaling Pathway
Jiang, Y., Zhang, J., Yu, S., Zheng, L., Shen, Y., Ju, W., & Lin, L. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207326666230519115845 · Cited by 1 · see citing works
Cancer Stem Cells and Competing Endogenous RNAsPreprint
Aria, H., Azizi, M., Nazem, S., Bahmanyar, M., Moravej, A., Pourjafarian, M. H., Pezeshki, B., Tavassoli, A., Vakil, M. K., & Mansoori, Y. (2022) · Preprints.org · doi:10.20944/preprints202207.0353.v1 · Cited by 1 · see citing works
LncRNA Interpreter: A Protein-Centric Pipeline for Mechanistic Analysis of Long Noncoding RNAsPreprint
Lin, X., Spindler, T. J., Fonseca, M. A. D. S., Corona, R. I., Seo, J.-H., Dezem, F. S., Li, L., Lee, J. M., Long, H. W., Sellers, T. A., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3271630
Ni, W.-J., Liu, F., Yu, S., Li, F., Zhu, J., Chen, Z., Cheng, Y., & Li, C. (2021) · Archives of Medical Science · doi:10.5114/aoms/118940
Non-coding RNAs in glioblastoma at a glance
Basso, J., Fortuna, A. C., Vitorino, R. M. P., Akimitsu, N., & Vitorino, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99873-4.00028-1
Bhaskaran, M., Surabhi, C., Nesamony, J., & Selvam, C. (2024) · Springer eBooks · doi:10.1007/978-981-19-3949-5_34-1
Bhaskaran, M., Surabhi, C., Nesamony, J., & Selvam, C. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_34
The Role of Noncoding RNA in MGMT ‐Positive Glioblastoma: A Narrative Review
Zhao, J., Chen, J., Bai, Y., Li, Y., Han, Y., Han, C., & Li, Y. (2026) · Cancer Medicine · doi:10.1002/cam4.72362
- Authors
- He, Z., Wang, Y., Huang, G., Wang, Q., Zhao, D., & Chen, L.
- Affiliations
- University of Electronic Science and Technology of China (CN)
- Kailuan General Hospital (CN)
- Corresponding author
- Zhao, Dongdong
- Chen, Longyi
- Venue
- Archives of Biochemistry and Biophysics
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 623-624
- Pages
- 1-8
- ISSN
- 0003-9861 (ISSN-L)
- OpenAlex
- W2580761780
- Cited by
- 83
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 8 · 2021: 12 · 2020: 9 · 2019: 15 · 2018: 21 · 2017: 8
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Biochemistry and Biophysics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sichuan Provincial Health Department Research Projects (130203)
- Youth fund of Sichuan Provincial People's Hospital (2015QN18)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Circular RNAs in diseases
- Keywords
- UCA1, long non-coding RNA, miR-182, iASPP, glioma, cell proliferation, cell migration, metastasis, prognostic factors, therapeutic target, lncRNA-miRNA interaction
- MeSH terms
- Brain, Brain Neoplasms, Cell Movement, Female, Glioma, Humans, Male, Middle Aged, Repressor Proteins, Gene Expression Regulation, Neoplastic, MicroRNAs, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Cell Proliferation, RNA, Long Noncoding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review